Division Chief, Internal Medicine
Internal Medicine
Dr. Andrew C. Adams, MD
|
|
Give Review
Doctor Andrew C. Adams, MD is an expert in the field of Internal Medicine. He researched medicine at Temple University School of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Andrew Adams is a published doctor as well. He has 19 publications published. The latest was: The Nuclear Receptor Rev-erb Regulates Adipose Tissue-Specific Fibroblast Growth Factor 21 (FGF21) Signaling. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The Sweetest Thing: Regulation of Macronutrient Preference by FGF21.
- Overexpression of β-klotho in adipose tissue sensitizes male mice to endogenous FGF21 and provides protection from diet-induced obesity.
- Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters.
- Inventing new medicines: The FGF21 story.
- FGF21: insights into mechanism of action from preclinical studies.
- Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21.
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice.
- Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo.
- Ablation of the hypothalamic neuropeptide melanin concentrating hormone is associated with behavioral abnormalities that reflect impaired olfactory integration.
- Rapid, reversible activation of AgRP neurons drives feeding behavior in mice.
- Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.
- A Very Low Carbohydrate Ketogenic Diet Improves Glucose Tolerance in ob/ob Mice Independent of Weight Loss.
- Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas.
- Fibroblast growth factor 21 is not required for the reductions in circulating insulin-like growth factor-1 or global cell proliferation rates in response to moderate c...
- Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones.
- LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys.
- Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice.
- The Nuclear Receptor Rev-erbα Regulates Adipose Tissue-Specific Fibroblast Growth Factor 21 (FGF21) Signaling.
Schools
Temple University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Allegheny General Hospital - Western Pennsylvania Hospital -
Temple University School of Medicine
Drug Facts
| NPI NUMBER | 1093911588 | |
| NPPES Provider LastName | ADAMS | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 152241779 | |
| NPPES Provider State | PA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 5291.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 262.0 | |
| Percent Opioid Claims | 4.95 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093911588 |
| Last Name Of The Provider | ADAMS |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
|
Dr. John D. Kristofic, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank J. Kroboth III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Fowler, DO |
|
|
Dr. Bhavana Bhagya Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Flynn, MD |
|
|
Dr. Stephen J. D'Auria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dipesh Maan, MD |
|
|
Dr. Rohit Rattan, MD |
|
|
Dr. Kia M. McLean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Puneet S. Devgun, DO |
|
|
Dr. John Montini, MD
This Doctor is OpenDoctor Recommended.
|